MRA Advisory Group Has $1.91 Million Position in Axon Enterprise, Inc. (NASDAQ:AXON)

MRA Advisory Group grew its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 64.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,205 shares of the biotechnology company's stock after acquiring an additional 1,255 shares during the quarter. Axon Enterprise accounts for 1.0% of MRA Advisory Group's holdings, making the stock its 22nd biggest position. MRA Advisory Group's holdings in Axon Enterprise were worth $1,905,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the business. Marion Wealth Management bought a new position in Axon Enterprise during the fourth quarter worth about $241,000. Friedenthal Financial lifted its position in shares of Axon Enterprise by 961.7% in the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company's stock valued at $808,000 after buying an additional 1,231 shares during the last quarter. Brookstone Capital Management boosted its stake in shares of Axon Enterprise by 27.0% during the 4th quarter. Brookstone Capital Management now owns 974 shares of the biotechnology company's stock worth $579,000 after acquiring an additional 207 shares during the period. Winthrop Advisory Group LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth approximately $236,000. Finally, Czech National Bank raised its stake in Axon Enterprise by 7.4% in the 4th quarter. Czech National Bank now owns 15,707 shares of the biotechnology company's stock valued at $9,335,000 after acquiring an additional 1,082 shares during the period. 79.08% of the stock is owned by institutional investors.

Insider Transactions at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 21,834 shares of the stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the transaction, the insider now owns 154,394 shares of the company's stock, valued at approximately $91,691,508.72. This represents a 12.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 50,545 shares of company stock valued at $30,721,337. Company insiders own 6.10% of the company's stock.

Axon Enterprise Price Performance

AXON stock traded up $11.12 during midday trading on Tuesday, reaching $579.80. The company had a trading volume of 508,957 shares, compared to its average volume of 688,316. Axon Enterprise, Inc. has a 1-year low of $246.99 and a 1-year high of $698.67. The stock has a 50 day moving average price of $610.03 and a 200-day moving average price of $452.93. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market capitalization of $44.21 billion, a price-to-earnings ratio of 149.82, a price-to-earnings-growth ratio of 14.19 and a beta of 1.04.

Analysts Set New Price Targets

A number of equities analysts have commented on AXON shares. JMP Securities lifted their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a "market outperform" rating in a research report on Thursday, October 31st. The Goldman Sachs Group lifted their target price on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a "buy" rating in a report on Wednesday, October 23rd. Morgan Stanley raised shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and increased their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Needham & Company LLC boosted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a "buy" rating in a report on Friday, November 8th. Finally, Robert W. Baird increased their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. One equities research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $504.92.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.